Genprex Management
Management criteria checks 3/4
Genprex's CEO is Ryan Confer, appointed in Sep 2016, has a tenure of 8.17 years. directly owns 0.19% of the company’s shares, worth $7.50K. The average tenure of the management team and the board of directors is 3.2 years and 4.3 years respectively.
Key information
Ryan Confer
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 8.2yrs |
| CEO ownership | 0.2% |
| Management average tenure | 3.2yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$23m |
| Jun 30 2024 | n/a | n/a | -US$26m |
| Mar 31 2024 | n/a | n/a | -US$28m |
| Dec 31 2023 | n/a | n/a | -US$31m |
| Sep 30 2023 | n/a | n/a | -US$31m |
| Jun 30 2023 | n/a | n/a | -US$30m |
| Mar 31 2023 | n/a | n/a | -US$28m |
| Dec 31 2022 | US$1m | US$393k | -US$24m |
| Sep 30 2022 | n/a | n/a | -US$24m |
| Jun 30 2022 | n/a | n/a | -US$21m |
| Mar 31 2022 | n/a | n/a | -US$19m |
| Dec 31 2021 | US$1m | US$345k | -US$21m |
| Sep 30 2021 | n/a | n/a | -US$19m |
| Jun 30 2021 | n/a | n/a | -US$18m |
| Mar 31 2021 | n/a | n/a | -US$19m |
| Dec 31 2020 | US$1m | US$351k | -US$18m |
| Sep 30 2020 | n/a | n/a | -US$15m |
| Jun 30 2020 | n/a | n/a | -US$15m |
| Mar 31 2020 | n/a | n/a | -US$14m |
| Dec 31 2019 | US$1m | US$300k | -US$11m |
| Sep 30 2019 | n/a | n/a | -US$12m |
| Jun 30 2019 | n/a | n/a | -US$11m |
| Mar 31 2019 | n/a | n/a | -US$14m |
| Dec 31 2018 | US$2m | US$225k | -US$12m |
| Sep 30 2018 | n/a | n/a | -US$10m |
| Jun 30 2018 | n/a | n/a | -US$8m |
| Mar 31 2018 | n/a | n/a | -US$3m |
| Dec 31 2017 | US$585k | US$180k | -US$3m |
Compensation vs Market: Insufficient data to establish whether Ryan's total compensation is reasonable compared to companies of similar size in the UK market.
Compensation vs Earnings: Ryan's compensation has been consistent with company performance over the past year.
CEO
Ryan Confer (42 yo)
8.2yrs
Tenure
US$1,135,943
Compensation
Mr. Ryan M. Confer, M.S. has been the Chief Financial Officer of Genprex, Inc. since September 2016 and serves as its Chief Executive Officer, President and Director since May 08, 2024. Mr. Confer has serv...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Medical Officer | 3.2yrs | US$947.11k | 0.048% $ 2.0k | |
| President | 8.2yrs | US$1.14m | 0.19% $ 7.5k | |
| Senior Vice President of Human Resources | 2.8yrs | no data | no data | |
| Senior Vice President of Intellectual Property & Licensing | 4.2yrs | no data | no data | |
| Senior Vice President of Regulatory Affairs & Quality | 1.3yrs | no data | no data | |
| Chairman of Scientific & Medical Advisory Board | no data | no data | no data |
3.2yrs
Average Tenure
Experienced Management: 0A8I's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$1.14m | 0.19% $ 7.5k | |
| Chairman of Scientific & Medical Advisory Board | no data | no data | no data | |
| Independent Director | 4.7yrs | US$161.61k | 0.024% $ 980.2 | |
| Strategic Advisor to the Board of Directors | 12.3yrs | no data | no data | |
| Member of Scientific & Medical Advisory Board | no data | no data | no data | |
| Member of Clinical Advisory Board | 3.8yrs | no data | no data | |
| Member of Scientific & Medical Advisory Board | no data | no data | no data | |
| Member of Scientific & Medical Advisory Board | no data | no data | no data | |
| Independent Director | 4.7yrs | US$151.16k | 0% $ 0 | |
| Independent Non-Executive Chairman | 4.7yrs | US$161.61k | 0% $ 0 | |
| Member of Scientific Advisory Board | 4yrs | no data | no data | |
| Member of Clinical Advisory Board | 3.8yrs | no data | no data |
4.3yrs
Average Tenure
66yo
Average Age
Experienced Board: 0A8I's board of directors are considered experienced (4.3 years average tenure).